Cite
HARVARD Citation
Awad, M. et al. (n.d.). 364 A personal neoantigen vaccine NEO-PV-01 in combination with chemotherapy and pembrolizumab induces broad de novo immune responses in first line, non-squamous NSCLC. Journal for immunotherapy of cancer. p. A222. [Online].